Table 4 Stratification analysis in patients with and without DM or HTN.
DM status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Patients without DM. | Patients with DM. | ||||||||||
Number of events | Adjuster ORa (95% CI) | P-value | Number of events | Adjuster ORa (95% CI) | P-value | ||||||
ESRD patients N = 136 | Controls N = 709 | ESRD patients N = 216 | Controls N = 1051 | ||||||||
Corneal oedema | 8 | 12 | 3.49 (1.36–8.91) | 0.0091 | 4 | 29 | 0.74 (0.26–2.17) | 0.5868 | |||
Glaucoma | 6 | 16 | 1.85 (0.67–5.08) | 0.2298 | 6 | 39 | 0.74 (0.31–1.78) | 0.4981 | |||
VH | 2 | 1 | 5.39 (0.22–131.37) | 0.3009 | 13 | 14 | 4.51 (1.98–10.28) | 0.0003 | |||
Dropped nucleus | 3 | 3 | 5.24 (0.97–28.37) | 0.0546 | 7 | 13 | 2.37 (0.89–6.32) | 0.0843 | |||
HTN status | |||||||||||
Patients without HTN | Patients with HTN | ||||||||||
Number of events | Adjuster ORa (95% CI) | P-value | Number of events | Adjuster ORa (95% CI) | P-value | ||||||
ESRD patients N = 83 | Controls N = 401 | ESRD patients N = 269 | Controls N = 1359 | ||||||||
Corneal oedema | 1 | 5 | 1.16 (0.13–10.34) | 0.8930 | 11 | 36 | 1.61 (0.80–3.23) | 0.1843 | |||
Glaucoma | 1 | 11 | 0.37 (0.04–3.19) | 0.3672 | 11 | 44 | 1.27 (0.64–2.52) | 0.4941 | |||
VH | 3 | 1 | 12.81 (0.89–185.28) | 0.0614 | 12 | 14 | 4.15 (1.79–9.63) | 0.0009 | |||
Dropped nucleus | 1 | 5 | 0.16 (0.01–4.00) | 0.2609 | 9 | 11 | 3.89 (1.55–9.76) | 0.0037 | |||